Related Experiment Video
Updated: Jul 11, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
[Development of gene delivery system using PLGA nanospheres]
Kohei Tahara1, Hiromitsu Yamamoto, Hirofumi Takeuchi
1Laboratory of Pharmaceutical Engineering, School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan. tahara@dpc.agu.ac.jp
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|October 6, 2007
Summary
Researchers developed chitosan-coated poly (lactide-co-glycolide) nanospheres (PLGA NS) as novel nonviral vectors for gene therapy. These nanocarriers show improved cellular uptake and sustained release, offering a promising alternative to conventional gene delivery systems.
Area of Science:
- Biomaterials Science
- Gene Therapy Delivery
- Nanotechnology
Background:
- Gene therapy requires efficient and safe nonviral vectors for cell delivery.
- Existing cationic nonviral vectors often face challenges with stability, gene expression duration, and cytotoxicity.
- Poly (lactide-co-glycolide) nanospheres (PLGA NS) modified with chitosan show potential for enhanced mucosal peptide absorption.
Purpose of the Study:
- To develop and evaluate novel chitosan-coated PLGA NS as nonviral vectors for gene therapy.
- To investigate the encapsulation of polynucleic acids within PLGA NS using a cationic lipid complexation strategy.
- To assess the cellular uptake, stability, and therapeutic effects of the developed nanospheres compared to conventional vectors.
Main Methods:
- Preparation of mucoadhesive PLGA nanospheres by modifying the surface with chitosan.
- Complexation of polynucleic acids (plasmid DNA, antisense oligonucleotide, small interfering RNA) with cationic lipid for dispersion.
- Encapsulation of polynucleic acid-lipid complexes into PLGA NS matrix using the emulsion solvent diffusion method.
- Evaluation of nanosphere characteristics, cellular uptake, and gene therapeutic effects.
Main Results:
- Successfully prepared chitosan-coated PLGA NS capable of encapsulating polynucleic acids.
- The emulsion solvent diffusion method provided a simple process without requiring ultrasonication.
- The resulting nanospheres demonstrated improved cellular adherence and sustained release of polynucleic acids.
- Enhanced cellular uptake and distinct gene therapeutic effects were observed compared to conventional vectors.
Conclusions:
- Chitosan-coated PLGA NS represent a promising advancement in nonviral vector technology for gene therapy.
- The developed nanocarriers offer improved characteristics for efficient and sustained gene delivery.
- This approach provides a viable alternative for nonviral gene delivery, potentially overcoming limitations of existing methods.
